- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Adolescent and young adult (AYA)
- Advanced practice provider (APP)
- Advocacy
- Bladder cancer
- Blood cancer
- Brain Cancer
- Breast cancer
- Cancer Research
- Cancer screening
- Cancer surveillance
- Cancer treatment
- Care delivery
- Chemotherapy
- Chronic lymphocytic leukemia (CLL)
- Clinical trial
- Colon Cancer
- Colorectal cancer
- ComboMATCH
- Data science
- Disparities
- Diversity
- Financial hardship
- Gallbladder cancer
- Gastric cancer
- Gene testing
- Genitourinary cancer
- Genomic testing
- Geriatric oncology
- GI cancer
- Glioblastoma
- Group meeting
- Head and neck cancer
- Health disparities
- Health equity
- Hogkin lymphoma
- Immunotherapy
- In memory
- Kidney cancer
- Leadership
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Mammography
- Medical breakthrough
- Melanoma
- Mentorship
- Multiple myeloma
- Myelodysplastic syndrome (MDS)
- Myeloma
- myeloMATCH
- Myeloproliferative neoplasms
- NCI-MATCH
- NCORP
- Non-Hodgkin lymphoma
- Pancreatic cancer
- Pancreatic cysts
- Penis cancer
- personalized medicine
- Personalized screening
- Personalized treatment
- Precision medicine
- Precision oncology
- PrECOG
- Prevention
- Prostate cancer
- Quality of life
- Radiology
- Real world data
- Renal cell carcinoma
- Research results
- Sarcoma
- Skin cancer
- Social determinants of health (SDoH)
- Stomach cancer
- Survivorship
- TAILORx
- Targeted therapy
- Thyroid cancer
- TMIST
- Travel scholarship
- Treatment trial
December 11, 2023
December 11, 2023
Categories
Do you like it?
December 11, 2023
December 11, 2023
Categories
Do you like it?
December 11, 2023
December 11, 2023
Categories
Do you like it?
November 15, 2023
November 15, 2023
Categories
Do you like it?
November 7, 2023
November 7, 2023
Categories
Do you like it?
July 20, 2023
July 20, 2023
Categories
Press Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative
Do you like it?
February 27, 2023
February 27, 2023
Categories
Do you like it?
February 23, 2023
February 15, 2023
February 15, 2023
Categories
Do you like it?